Teva Pharmaceutical Industries (NYSE:TEVA) Stock Rating Upgraded by JPMorgan Chase & Co.
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Monday, MarketBeat reports. The brokerage presently has a $23.00 target price on the stock, up from their previous target price of $21.00. JPMorgan Chase & Co.‘s target […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Monday, MarketBeat reports. The brokerage presently has a $23.00 target price on the stock, up from their previous target price of $21.00. JPMorgan Chase & Co.‘s target […]
